Independent Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$458K Buy
5,857
+975
+20% +$66.5K 0.01% 1037
2026
Q1
$316K Buy
4,882
+133
+3% +$9.38K 0.01% 1135
2025
Q4
$320K Buy
4,749
+267
+6% +$18K 0.01% 1119
2025
Q3
$329K Buy
4,482
+323
+8% +$21.5K 0.01% 1045
2025
Q2
$216K Buy
4,159
+12
+0.3% +$683 0.01% 1189
2025
Q1
$265K Buy
+4,147
New +$241K 0.01% 981
2024
Q4
Sell
-3,834
Closed -$219K 1194
2024
Q3
$219K Buy
+3,834
New +$220K 0.01% 1025

Other funds holding HALO

Independent Financial Group's HALO Position: Q2 2026 in Review

Independent Financial Group increased its Halozyme (HALO) stake by 20% in Q2 2026, buying an estimated $66.5K and bringing the position to 5,857 shares worth $458K. The position accounts for 0.01% of the portfolio, ranked #1037.

Independent Financial Group first reported a position in HALO in Q3 2024 and has held it in 7 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Independent Financial Group held 5,857 shares of Halozyme worth $458K as of Q2 2026.
  • Independent Financial Group bought 975 Halozyme shares in Q2 2026, an estimated $66.5K.
  • Halozyme made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #1037 holding.
  • Independent Financial Group first reported a position in Halozyme in Q3 2024 and has held it in 7 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.